Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor-α concentration

British Journal of Haematology

Volumn 99, Issue 3, 1997, Pages 625-631

  Peddie, Clare M ^a   Wolf, C Roland ^a   Mclellan, Lesley I ^a   Collins, Andrew R ^b   Bowen, David T ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Apoptosis; Glutathione; Myelodysplasia; Oxidative; TNF

Indexed keywords

AMIFOSTINE; CD34 ANTIGEN; GLUTATHIONE; OXYGEN RADICAL; PYRIMIDINE NUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DNA DAMAGE; HEMATOPOIESIS; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0030664927     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4373247.x     Document Type: Article

References (32)

1. 4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood, 86, 258-267.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
3. Bogdanovic, A.D., Trpinac, D.P., Jankovic, G.M., Bumbasirevic, V.Z., Obradovic, M. & Colovic, M.D. (1997) Incidence and role of apoptosis in myelodysplastic syndrome: morphological and ultrastructural assessment. Leukemia, 11, 656-659.
4. Collins, A.R., Dusinska, M., Gedik, C.M. & Stetina, R. (1996) Oxidative damage to DNA: do we have a reliable biomarker. Environmental Health Perspectives, 104, 465-469.
5. Collins, A.R., Duthie, S.J. & Dobson, V.L. (1993) Direct enzymatic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis, 14, 1733-1735.
6. Collins, A.R., Ma, A.G. & Duthie, S.J. (1995) The kinetics of repair of oxidative DNA damage (strand breaks and oxidized pyrimidines) in human cells. Mutation Research-DNA Repair, 336, 69-77.
7. Degan, P., Bonassi, S., De Caterina, M., Korkina, L.G., Pinto, L., Scopacasa, F., Zatterale, A., Calzone, R. & Pagano, G. (1995) In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis, 16, 735-741.
8. Dirks, W., Schone, S., Uphoff, C., Quentmeier, H., Pradella, S. & Drexler, H.G. (1997) Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines. British Journal of Haematology, 96, 584-593.
9. Dreher, D. & Junod, A.F. (1996) Role of oxygen-free radicals in cancer development. European Journal of Cancer, 32A, 30-38.
10. Droge, W., Eck, H.P. & Mihm, S. (1994) Oxidant-antioxidant status in human immunodeficiency virus infection. Methods in Enzymology, 233, 594-601.
11. Duthie, S.J., Ma, A., Ross, M.A. & Collins, A.R. (1996) Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Research, 56, 1291-1295.
12. Ganser, A., Maurer, A., Contzen, C., Seipelt, G., Ottmann, O.G., Schadeckgressel, C., Kolbe, K., Haas, R., Zander, C., Reutzel, R. & Hoelzer, D. (1996) Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte-colony-stimulating factor, erythropoietin and alpha-tocopherol. Annals of Hematology, 72, 237-244.
13. Gersuk, G.M., Yamaguchi, M., Beckham, C., Kiener, P., Anderson, J.E., Trout, T., Loken, M.R. & Deeq, H.J. (1996) A role for Fas, Fas-ligand and TNF-α in the dysregulation of hematopoiesis in myelodysplastic syndrome (MDS). Blood, 88, 2543.
14. Hatake, K., Tomizuka, H., Ikeda, M., Tsunoda, J.-I., Hoshino, Y., Ohtsuki, T., Kasahara, T., Yonehara, S. & Miura, Y. (1993) The presence of apoptosis in refractory anemia of myelodysplasia. Molecular Biology of Hematopoises, 3, 127-133.
15. Janssen, J.W., Steenvoorden, A.C., Lyons, J., Anger, B., Bohlke, J.U., Bos, J.L., Seliger, H. & Bartram, C.R. (1987) RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proceedings of the National Academy of Sciences of the United States of America, 84, 9228-9232.
16. Kaneko, H., Horiike, S., Taniwaki, M., & Misawa, S. (1996) Microsatellite instability is an early genetic event in myelodysplastic syndromes but is infrequent and not associated with TGF-β receptor type II gene mutation. Leukemia, 10, 1696-1699.
17. Kitagawa, M., Kamiyama, R. & Kasuga, T. (1993) Increase in number of bone-marrow macrophages in patients with myelodysplastic syndromes. European Journal of Haematology, 51, 56-58.
18. Lepelley, P., Campergue, L., Grardel, N., Preudhomme, C., Cosson, A. & Fenaux, P. (1996) Is apoptosis a massive process in myelodysplastic syndromes? British Journal of Haematology, 95, 368.
19. List, A.F., Heaton, R., Glinsmann-Gibson, B., Brasfield, F., Crook, L., Chartrand, C., Taetle, R. & Kurman, M. (1996) Amifostine promotes multilineage hematopoiesis in patients with myelodysplastic syndrome (MDS): results of a phase I/II clinical trial. (Abstract). Blood, 88, 453a.
20. List, A.F., Heaton, R., Glinsmann-Gibson, B. & Capizzi, R.L. (1995) Amifostine is a novel stimulant of bone marrow progenitor growth in myelodysplastic syndromes. (Abstract). Blood, 86, 335a.
21. + cells of patients with aplastic anaemia. British Journal of Haematology, 91, 245-252.
22. Padua, R.A., Carter, G., Hughes, D., Gow, J., Farr, C., Oscier, D., McCormick, F. & Jacobs, A. (1988) Ras mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. Leukemia, 2, 503-510.
23. Rajapaksa, R., Ginzton, N., Rott, L.S. & Greenberg, P.L. (1996) Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood, 88, 4275-4287.
24. Raza, A., Gezer, S., Mundle, S., Gao, X.-Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S. & Preisler, H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268-276.
25. Selleri, C., Sato, T., Anderson, S., Young, N.S. & Maciejewski, J.P. (1995) Interferon-gamma and tumor-necrosis-factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell-death. Journal of Cellular Physiology, 165, 538-546.
26. Shetty, V., Mundle, S., Alvi, S., Showel, M., Broadyrobinson, L., Dar, S., Borok, R., Showel, J., Gregory, S., Rifkin, S., Gezer, S., Parcharidou, A., Venugopal, P., Shah, R., Hernandez, B., Klein, M., Alston, D., Robin, E., Dominquez, C. & Raza, A. (1996) Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leukemia Research, 20, 891-900.
27. Shojl, Y., Ishikura, U.H., Takeyama, N. & Tanaka, T. (1995) DNA damage induced by tumour necrosis factor-α in L929 cells is mediated by mitochondrial oxygen radical formation. Immunology, 84, 543-548.
28. Singh, N.P., McCoy, M.T., Tice, R.R. & Schneider, E.L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research, 175, 184-191.
29. Slater, A.F.G., Stefan, C., Nobel, I., Vandendobbelsteen, D.J. & Orrenius, S. (1996) Intracellular redox changes during apoptosis. Cell Death and Differentiation, 3, 57-62.
30. Verhoef, G.E.G., De Schouwer, P., Ceuppens, J.L., Van Damme, J., Gooseens, W. & Boogaerts, M.A. (1992) Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia, 6, 1268-1272.
31. Winters, R.A., Zukowski, J., Ercal, N., Matthews, R.H. & Spitz, D.R. (1995) Analysis of glutathione, glutathione disulfide, cysteine, homocysteine, and other biological thiols by high-performance liquid-chromatography following derivatization by n-(1-pyrenyl)-maleimide. Analytical Biochemistry, 227, 14-21.
32. Yang, E. & Korsmeyer, S.J. (1996) Molecular thanatopsis: a discourse on the bcl2 family and cell death. Blood, 88, 386-401.